An open label randomized controlled trial to evaluate the efficacy of Bhunimbadi Vati and its add on effect with Tablet Glimepiride Metformin in the management of Madhumeha with special reference to Type 2 Diabetes mellitus

Dr Kiran Damoo Ubhe0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•1. Age group- between 40-70 years
•2. Gender- Male & female both
•3. Known case of Madhumeha according to symptoms- patient passes frequently, large
•quantity and turbid urine (Prabhutaavilamutrata).
•Type II diabetic having symptomsPolyphagia, Polyuria, Polydipsia, on treatment and newly diagnosed Type II diabetic who
•are suffering for not more than 10 years.
•4. Patients with fasting blood sugar more than 126-250 mg/dl and post prandial blood sugar
•more than 200-350 mg/dl.
•(Patients with fasting blood sugar more than 126 mg/dl and post prandial blood sugar
•more than 200 mg/dl)
•5. Patients having HbA1c 6.5-10%

•1. K/C/O Madhumeha who are already taking Ayurvedic medicine for same.
•2. K/C/O Type 1 Diabetes, K/C/O Acromegaly, K/C/O Cushingâ??s syndrome, K/C/O pancreatic disorder
•3. Patient under insulin therapy
•4. Pregnant and lactating mothers
•5. Patients with acute complications like hyperglycemic coma, ketoacidosis and infections like gangrene
•6. K/C/O Nephropathy, K/C/O Neuropathy, K/C/O retinopathy
•7. Patients with immune compromised disease

发起方

Dr Kiran Damoo Ubhe